You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
A new treatment method has been discovered for lipoatrophy, a rare but problematic complication of type 1 diabetes. The condition is an adverse effect of the immune system's interaction with insulin that results in dents in the skin at insulin injection sites. These dents are caused by atrophy of the tissue directly beneath the skin.
Insulin is known to produce allergic and immunological reactions in some people. In such a reaction, the body's immune system attacks the foreign substance, like it would a disease-causing bacteria.
Lipoatrophy is an example of this type of immune system response. It includes the production of cytokines, proteins that work as mediators between the cells in the "infected" area and help generate the response.
In a study published in the November 1996 issue of Diabetes Care researchers hypothesized that the cytokines might also cause the tissue atrophy at injection sites. In laboratory experiments researchers found that dexamethasone, an anti-inflammatory medication, inhibited the production of cytokines.
After these laboratory findings, dexamethasone was used on a 25-year-old woman with lipoatrophy on her arms, abdomen and hips. A mixture of insulin and dexamethasone was injected directly into her lipoatrophic injection sites. This treatment had no effect on the patient's metabolic control and her daily insulin requirements did not change. After 12 months of treatment, all of her lipoatrophic areas disappeared.
0 comments - Feb 1, 1997
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.